220 related articles for article (PubMed ID: 34114647)
1. Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-function.
Shamriz O; Lev A; Simon AJ; Barel O; Javasky E; Matza-Porges S; Shaulov A; Davidovics Z; Toker O; Somech R; Zlotogorski A; Molho-Pessach V; Tal Y
Clin Exp Immunol; 2021 Oct; 206(1):56-67. PubMed ID: 34114647
[TBL] [Abstract][Full Text] [Related]
2. Case Report: A New Gain-of-Function Mutation of
Martinot M; Korganow AS; Wald M; Second J; Birckel E; Mahé A; Souply L; Mohseni-Zadeh M; Droy L; Tarabeux J; Okada S; Migaud M; Puel A; Guffroy A
Front Immunol; 2021; 12():760019. PubMed ID: 34987506
[TBL] [Abstract][Full Text] [Related]
3. STAT1 gain-of-function and chronic demodicosis.
Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
[TBL] [Abstract][Full Text] [Related]
4. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
5. Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1.
Baris S; Alroqi F; Kiykim A; Karakoc-Aydiner E; Ogulur I; Ozen A; Charbonnier LM; Bakır M; Boztug K; Chatila TA; Barlan IB
J Clin Immunol; 2016 Oct; 36(7):641-8. PubMed ID: 27379765
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations.
Leiding JW; Okada S; Hagin D; Abinun M; Shcherbina A; Balashov DN; Kim VHD; Ovadia A; Guthery SL; Pulsipher M; Lilic D; Devlin LA; Christie S; Depner M; Fuchs S; van Royen-Kerkhof A; Lindemans C; Petrovic A; Sullivan KE; Bunin N; Kilic SS; Arpaci F; Calle-Martin O; Martinez-Martinez L; Aldave JC; Kobayashi M; Ohkawa T; Imai K; Iguchi A; Roifman CM; Gennery AR; Slatter M; Ochs HD; Morio T; Torgerson TR;
J Allergy Clin Immunol; 2018 Feb; 141(2):704-717.e5. PubMed ID: 28601685
[TBL] [Abstract][Full Text] [Related]
7. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
[TBL] [Abstract][Full Text] [Related]
8. Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature.
Deyà-Martínez A; Rivière JG; Roxo-Junior P; Ramakers J; Bloomfield M; Guisado Hernandez P; Blanco Lobo P; Abu Jamra SR; Esteve-Sole A; Kanderova V; García-García A; Lopez-Corbeto M; Martinez Pomar N; Martín-Nalda A; Alsina L; Neth O; Olbrich P
J Clin Immunol; 2022 Jul; 42(5):1071-1082. PubMed ID: 35486339
[TBL] [Abstract][Full Text] [Related]
9. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome.
Largent AD; Lambert K; Chiang K; Shumlak N; Liggitt D; Oukka M; Torgerson TR; Buckner JH; Allenspach EJ; Rawlings DJ; Jackson SW
Sci Transl Med; 2023 Jul; 15(703):eade7028. PubMed ID: 37406138
[TBL] [Abstract][Full Text] [Related]
11. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice.
Tamaura M; Satoh-Takayama N; Tsumura M; Sasaki T; Goda S; Kageyama T; Hayakawa S; Kimura S; Asano T; Nakayama M; Koseki H; Ohara O; Okada S; Ohno H; Kobayashi M
Int Immunol; 2020 Apr; 32(4):259-272. PubMed ID: 31867619
[TBL] [Abstract][Full Text] [Related]
12. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation.
Kayaoglu B; Kasap N; Yilmaz NS; Charbonnier LM; Geckin B; Akcay A; Eltan SB; Ozturk G; Ozen A; Karakoc-Aydiner E; Chatila TA; Gursel M; Baris S
J Clin Immunol; 2021 May; 41(4):769-779. PubMed ID: 33475942
[TBL] [Abstract][Full Text] [Related]
13. Bronchiectasis and Recurrent Respiratory Infections with a
Huh HJ; Jhun BW; Choi SR; Kim YJ; Yun SA; Nham E; Kong T; Ki CS; Koh WJ
Yonsei Med J; 2018 Oct; 59(8):1004-1007. PubMed ID: 30187709
[TBL] [Abstract][Full Text] [Related]
14. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
Okada S; Asano T; Moriya K; Boisson-Dupuis S; Kobayashi M; Casanova JL; Puel A
J Clin Immunol; 2020 Nov; 40(8):1065-1081. PubMed ID: 32852681
[TBL] [Abstract][Full Text] [Related]
15. STAT1 and STAT3 mutations: important lessons for clinical immunologists.
Olbrich P; Freeman AF
Expert Rev Clin Immunol; 2018 Dec; 14(12):1029-1041. PubMed ID: 30280610
[TBL] [Abstract][Full Text] [Related]
16. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
Front Immunol; 2021; 12():654406. PubMed ID: 33777053
[No Abstract] [Full Text] [Related]
18. Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review.
Wang X; Zhao W; Chen F; Zhou P; Yan Z
Mycopathologia; 2023 Apr; 188(1-2):87-97. PubMed ID: 36335528
[TBL] [Abstract][Full Text] [Related]
19. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
[TBL] [Abstract][Full Text] [Related]
20. Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib.
Dotta L; Todaro F; Baronio M; Giacomelli M; Pinelli M; Giambarda M; Brognoli B; Greco S; Rota F; Cortesi M; Soresina A; Moratto D; Tomasi C; Ferraro RM; Giliani S; Badolato R
J Clin Immunol; 2024 Apr; 44(4):85. PubMed ID: 38578354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]